Remdesivir in moderate to severe COVID-19: A matter of time?

被引：0

作者：

Bonazzetti, Cecilia ^{[1
,2
]}

Giacomelli, Andrea ^{[1
,2
]}

Pavia, Martina ^{[2
]}

Fusetti, Chiara ^{[1
,2
]}

Gerbi, Martina ^{[1
,2
]}

Petri, Francesco ^{[1
,2
]}

Poloni, Andrea ^{[1
,2
]}

Oreni, Letizia ^{[1
]}

Ridolfo, Anna Lisa ^{[1
]}

Antinori, Spinello ^{[1
,2
]}

机构：

[1] Luigi Sacco Univ Hosp, Dept Infect Dis, ASST Fatebenefratelli Sacco, Milan, Italy

[2] Univ Milan, Luigi Sacco Dept Biomed & Clin Sci, Milan, Italy

来源：

关键词：

D O I：

10.1016/j.phrs.2021.105711

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页数：2

共 50 条

[31] Outpatient Remdesivir to Prevent Progression to Severe Covid-19 REPLY
Gottlieb, Robert L.
Juneja, Kavita
Hill, Joshua A.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (11): : 1094 - 1094
[32] Patients with moderate to severe COVID-19 outcomes on remdesivir according to baseline 4C mortality score
Sellers, Jacob
Chang, Jongwha
Jones, Jessica
Hintze, Trager D.
[J]. PULMONARY PHARMACOLOGY & THERAPEUTICS, 2023, 78
[33] Remdesivir bei COVID-19
Redaktion Facharztmagazine
[J]. MMW - Fortschritte der Medizin, 2022, 164 (2) : 65 - 65
[34] Remdesivir (Veklury) for COVID-19
不详
[J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2020, 62 (1612): : 186 - 188
[35] Remdesivir for patients with COVID-19
Wu, Peter E.
Morris, Andrew M.
[J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2021, 193 (04) : E125 - E125
[36] COVID-19: Is Remdesivir the Cure?
不详
[J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2020, 145 (13)
[37] Remdesivir: A Review in COVID-19
Blair, Hannah A.
[J]. DRUGS, 2023, 83 (13) : 1215 - 1237
[38] Remdesivir for patients with COVID-19
Wu, Peter E.
Morris, Andrew M.
[J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2021, 193 (14) : E495 - E496
[39] Efficacy of Remdesivir in COVID-19
McCreary, Erin K.
Angus, Derek C.
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (11): : 1041 - 1042
[40] Timing of Remdesivir for COVID-19
不详
[J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2020, 62 (1609): : 161 - 161